CONVERGENCE PHARMACEUTICALS

Convergence Pharmaceuticals is an independent biotechnology company focused on the development of novel analgesics with potentially commercially attractive efficacy, responder-rate and side effect profiles. The Company was formed in October 2010 following the acquisition of certain neuroscience clinical assets from GlaxoSmithKline (â€œGSKâ€). Convergence Pharmaceuticals has a pipeline of differentiated clinical-stage compounds targeting the points of convergence in chronic pain signaling through modulation of specific ion-channels.

#People #Financial #Website #More

CONVERGENCE PHARMACEUTICALS

Industry:

Biotechnology Health Care Medical Neuroscience

Founded:

2010-01-01

Address:

Cambridge, Cambridgeshire, United Kingdom

Country:

United Kingdom

Website Url:

http://www.convergencepharma.com

Total Employee:

11+

Status:

Closed

Contact:

44 1223 755 501

Email Addresses:

[email protected]

Total Funding:

35.4 M USD

Technology used in webpage:

SPF Amazon AWS Global Accelerator

Current Advisors List

liam-ratcliffe_image

Liam Ratcliffe Board of Directors @ Convergence Pharmaceuticals
Board_member

Current Employees Featured

not_available_image

Brenda Reynolds
Brenda Reynolds Founder & COO @ Convergence Pharmaceuticals
Founder & COO

Founder

not_available_image

Brenda Reynolds

clive-dix_image

Clive Dix

Investors List

new-leaf-venture-partners_image

New Leaf Venture Partners

New Leaf Venture Partners investment in Series A - Convergence Pharmaceuticals

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series A - Convergence Pharmaceuticals

apposite-capital_image

Apposite Capital

Apposite Capital investment in Series A - Convergence Pharmaceuticals

Official Site Inspections

http://www.convergencepharma.com

Host Informations
Whois Informations

Loading ...

More informations about "Convergence Pharmaceuticals" on Search Engine